MedTrace Logo

Effects of Oral Zinc Gluconate Among Acne Vulgaris Patients

NCT05096312 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2022-05-11

Study results available
· View outcomes & findings →

Summary

Acne Vulgaris is one of the most common dermatologic diagnoses requiring long-term maintenance therapy. Promising results of oral zinc gluconate in improving acne vulgaris has been described.

A randomized, double blind, placebo-controlled clinical trial was utilized for this study with the objective to assess the efficacy of oral zinc gluconate in the improvement of disease activity in acne vulgaris patients as measured by the inflammatory score and Global Acne Grading System (GAGS) score.

Conditions

  • Acne Vulgaris

Interventions

DIETARY_SUPPLEMENT

Zinc gluconate

oral zinc gluconate 200mg

DRUG

Adapalene 0.003 MG/MG / Benzoyl Peroxide 0.025 MG/MG Topical Gel [Epiduo]

Adapalene 0.3% + Benzoyl peroxide 2.5% gel applied once daily in the evening

OTHER

Placebo

contains cornstarch

Sponsors & Collaborators

  • East Avenue Medical Center, Philippines

    lead OTHER_GOV

Principal Investigators

  • Monique Lianne C. Lim-Ang, MD,MBA,DPDS · East Avenue Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
27 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-21
Primary Completion
2019-07-19
Completion
2019-07-20
FDA Drug
Yes

Countries

  • Philippines

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05096312 on ClinicalTrials.gov